PF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
More Information Supplier PagePF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
More Information Supplier PagePF-2545920 is a phosphodiesterase inhibitor selective for the PDE10A subtype.
More Information Supplier PagePF-2545920 is a phosphodiesterase inhibitor selective for the PDE10A subtype.
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageWAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageRibitol is a crystalline pentose alcohol formed by the reduction of ribose.
More Information Supplier Page
